Literature DB >> 1970071

Modern vaccines. Mycobacterial diseases.

P E Fine1, L C Rodrigues.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 1970071     DOI: 10.1016/0140-6736(90)91074-k

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  29 in total

1.  Controlling leprosy.

Authors:  C Lienhardt; P E Fine
Journal:  BMJ       Date:  1992-07-25

2.  Treatment strategies in the prevention of tuberculosis.

Authors:  T L Petty
Journal:  West J Med       Date:  1992-10

3.  A complication of BCG vaccine: A case of localized cutaneous abscess due to Mycobacterium bovis.

Authors:  N Lussier; A M Bourgault; C Gaudreau; P Turgeon
Journal:  Can J Infect Dis       Date:  1999-05

Review 4.  Pharmacoeconomics of antibacterial treatment.

Authors:  P G Davey; M M Malek; S E Parker
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

5.  Tuberculosis in a contact.

Authors:  A Bush; J O Warner
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

6.  Isolation and Identification of Environmental Mycobacteria in the Mycobacterium bovis BCG Trial Area of South India.

Authors:  T Kamala; C N Paramasivan; D Herbert; P Venkatesan; R Prabhakar
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

7.  Designing a vaccine for tuberculosis.

Authors:  A S Malin; D B Young
Journal:  BMJ       Date:  1996-06-15

8.  Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.

Authors:  H McShane; R Brookes; S C Gilbert; A V Hill
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

9.  Heterogeneity of the repertoire of T cells of tuberculosis patients and healthy contacts to Mycobacterium tuberculosis antigens separated by high-resolution techniques.

Authors:  B Schoel; H Gulle; S H Kaufmann
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

10.  Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Pascale C van Weeren; Fatima Kazi; Annemieke Geluk; Nigel D L Savage; Jan W Drijfhout; Darren R Flower; Willem A Hanekom; Michèl R Klein; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2010-02-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.